Cyxone
0,666 SEK +3,9 %Vær den første som følger denne virksomhed
Cyxone is a biotechnology company. The company's specialist expertise is found in the development of pharmaceuticals with a focus on plant protein as a base. The pharmaceutical is intended to be used mainly in the treatment of immune-related diseases, and the products are based on cyclotide technology. The purpose is that the pharmaceutical will be used in the treatment of multiple sclerosis and rheumatoid arthritis. Cyxone's head office is located in Malmö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CYXO
Daglig lav / høj pris
0,633 / 0,689
SEK
Markedsværdi
65,56 mio. SEK
Aktieomsætning
11,05 t SEK
Volumen
17 t
Seneste videoer
Finanskalender
Delårsrapport
30.08.2023
Delårsrapport
27.10.2023
Årsrapport
23.02.2024
Viser Alle indholdstyper